Skip to main content

Table 2 Cancer diagnoses of women undergoing fertility preservation

From: Responses to fertility treatment among patients with cancer: a retrospective cohort study

Pre-therapy diagnosis n (%)
Breast 79 (53.7)
Breast cancer typea
 Estrogen Receptor Positive 64 (81.0)
 Estrogen Receptor Negative 15 (19.0)
 Inflammatory 2 (2.5)
 HER-2 Positive 18 (22.8)
BRCA statusb
 Negative 51 (64.6)
 BRCA-1 Positive 7 (8.9)
 BRCA-2 Positive 6 (7.6)
 BRCA-1 and − 2 Positive 0 (0.0)
Gynecologic 8 (5.4)
 Ovarian 1 (0.7)
 Endometrial 4 (2.7)
 Cervical 5 (3.4)
Hematologic 38 (25.9)
 Leukemia 11 (7.5)
 Hodgkin’s lymphoma 18 (12.2)
 Non-Hodgkin’s lymphoma 1 (0.7)
 Myelodysplasia 2 (1.4)
Gastrointestinal 6 (4.1)
Brain 6 (4.1)
Other 11 (7.5)
Total 147c (100)
  1. a Breast cancer type percentages reported as percent of all breast cancers
  2. b BRCA status percentages reported as percent of all breast cancers. Fifteen patients had an unknown BRCA mutation carrier status
  3. c One patient was diagnosed with both primary breast and thyroid (other) malignancy at the same time, and is thus only represented once in the Total row